Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective Study

Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective Study

Sodium-glucose cotransporter inhibitors (SGLT2i) have demonstrated a reduction in cardiovascular events in diabetes and heart failure (HF). The mechanisms underlying this benefit are not well known and data are contradictory. The purpose of this study is to analyse the effect of dapagliflozin on car...

Full description

Bibliographic Details
Main Authors: Marcelino Cortés, Oscar Lorenzo, Jairo Lumpuy-Castillo, Sacramento Martínez-Albaladejo, Mikel Taibo-Urquía, Ana María Pello, Antonio José Bollas, Miguel Orejas, Miguel Ángel Navas, Ester Macia, María Esther Martínez, Andrea Rueda, Jose Tuñón
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Journal of Clinical Medicine
Subjects:
sodium-glucose cotransporter type 2 inhibitors
dapagliflozin
speckle tracking
biomarkers
echocardiography
Online Access:https://www.mdpi.com/2077-0383/12/20/6698

Internet

https://www.mdpi.com/2077-0383/12/20/6698

Similar Items